NCT06013202 is a NA clinical trial of Nigella Sativa Oil Mouth Rinse in Aphthous Ulcer, sponsored by Nada Sherif.

Who is sponsoring NCT06013202?

NCT06013202 is sponsored by Nada Sherif.

What drugs are being tested in NCT06013202?

Interventions in NCT06013202: Nigella Sativa Oil Mouth Rinse, isotonic (normal saline) with concentration 0.90% of sodium chloride (NaCl).

What condition does NCT06013202 study?

NCT06013202 studies Aphthous Ulcer.

Is NCT06013202 still recruiting?

NCT06013202 is currently status unknown. Last updated 29 August 2023.

Last reviewed 2023-08-29 · How we verify

NCT06013202

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Efficacy of Nigella Sativa Oil Mouth Rinse in the Management of Recurrent Minor Aphthous Ulcer

Status unknown NA Last updated 29 August 2023

What this trial tests

NA trial testing Nigella Sativa Oil Mouth Rinse in Aphthous Ulcer in 20 participants. Status unknown.

Timeline

22 September 2023

Primary endpoint
12 April 2024

22 September 2024

Quick facts

Lead sponsor	Nada Sherif
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	20
Start date	22 September 2023
Primary completion	12 April 2024
Estimated completion	22 September 2024
Sites	1 location across Egypt

Drugs / interventions tested

Nigella Sativa Oil Mouth Rinse
isotonic (normal saline) with concentration 0.90% of sodium chloride (NaCl)

Conditions studied

Aphthous Ulcer — all drugs for Aphthous Ulcer →

Sponsor

Nada Sherif

Who can join

Adults 25 to 65, any sex, with Aphthous Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research aims to investigate the effectiveness of Nigella Sativa Oil Mouth Rinse application both clinically and biochemically as a suitable affordable treatment modality for Management of Recurrent Minor Aphthous Ulcer

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aphthous Ulcer

Currently open trials in the same condition.

NCT07141758 — Salivary E-cadherin, Calprotectin, and Matrix Metalloproteinase-9 Levels in Recurrent Aphthous Stomatitis · recruiting
NCT06819033 — Effects of Photobiomodulation (PBM) on Pain After Presentation of Aphthous Ulcers in Pediatric Dental Patients · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06013202 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nada Sherif
Last refreshed: 29 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06013202.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing